![Isabelle Riviere](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Isabelle Riviere
Direktor/Vorstandsmitglied bei Centre For Commercialization of Cancer Immunotherapy
Aktive Positionen von Isabelle Riviere
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Centre For Commercialization of Cancer Immunotherapy
![]() Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Isabelle Riviere
Ehemalige bekannte Positionen von Isabelle Riviere
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JUNO THERAPEUTICS INC | Gründer | 05.08.2013 | - |
Statistik
International
Vereinigte Staaten | 2 |
Kanada | 2 |
Operativ
Founder | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Juno Therapeutics, Inc.
![]() Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Centre For Commercialization of Cancer Immunotherapy
![]() Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. |
- Börse
- Insiders
- Isabelle Riviere
- Erfahrung